ABN Amro Investment Solutions Sells 1,956 Shares of Axon Enterprise, Inc $AXON

Key Points

• ABN Amro Investment Solutions reduced its Axon Enterprise stake by 25.1% in the second quarter, selling 1,956 shares and retaining 5,849 shares valued at approximately $3.28 million. Institutional investors collectively own 79.08% of the company.
• Axon reported quarterly earnings of $1.88 per share versus the $1.84 consensus estimate, while revenue reached $904.39 million, up 35.3% year over year and ahead of expectations.
• Analysts remain broadly optimistic, with a “Moderate Buy” consensus rating and an average price target of $730.92, although Axon’s elevated valuation— including a P/E ratio above 255—presents a potential risk.

ABN Amro Investment Solutions cut its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 25.1% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,849 shares of the biotechnology company's stock after selling 1,956 shares during the quarter. ABN Amro Investment Solutions' holdings in Axon Enterprise were worth $3,279,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Darwin Wealth Management LLC acquired a new position in shares of Axon Enterprise during the second quarter valued at $37,000. Creative Financial Designs Inc. ADV bought a new stake in shares of Axon Enterprise in the fourth quarter valued at about $28,000. Camelot Portfolios LLC acquired a new position in Axon Enterprise during the fourth quarter worth $30,000. AlphaCentric Advisors LLC bought a new position in Axon Enterprise in the fourth quarter valued at approximately $34,000. Finally, Strive Financial Group LLC bought a new stake in shares of Axon Enterprise in the 4th quarter valued at about $41,000. 79.08% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently commented on AXON. JPMorgan Chase & Co. upped their target price on Axon Enterprise from $750.00 to $755.00 and gave the company an "overweight" rating in a research report on Thursday, May 7th. Zacks Research downgraded Axon Enterprise from a "strong-buy" rating to a "hold" rating in a report on Friday, July 10th. Needham & Company LLC reissued a "buy" rating on shares of Axon Enterprise in a research note on Thursday, August 6th. The Goldman Sachs Group restated a "buy" rating and issued a $715.00 target price on shares of Axon Enterprise in a report on Thursday, August 6th. Finally, TD Cowen reiterated a "buy" rating on shares of Axon Enterprise in a research note on Wednesday, July 22nd. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $730.92.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $615.59 on Friday. The company's 50 day moving average price is $523.52 and its two-hundred day moving average price is $473.43. The stock has a market cap of $50.01 billion, a P/E ratio of 255.43, a P/E/G ratio of 12.24 and a beta of 1.39. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $794.29. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.84 by $0.04. The firm had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The business's revenue for the quarter was up 35.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.12 EPS. On average, equities analysts predict that Axon Enterprise, Inc will post 1.63 earnings per share for the current year.

Key Headlines Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Strong Q2 results and raised outlook: Axon exceeded expectations with adjusted earnings of $1.88 per share versus $1.84 expected and revenue of $904.4 million versus $876.4 million expected. Revenue grew 35.3% year over year, and management’s improved outlook supports the long-term growth story. Should You Buy, Hold or Sell AXON Stock Post Q2 Earnings Release?
• Positive Sentiment: Connected Devices momentum: TASER devices, body cameras and counter-drone products are driving strong hardware demand. Continued adoption of these products, combined with Axon’s cloud-based evidence and records software, reinforces the company’s integrated platform strategy. Will Strength in Connected Devices Unit Continue to Drive AXON’s Growth?
• Positive Sentiment: Bullish strategic commentary: Analysts highlighted Axon as a strong contender in law-enforcement technology, while coverage pointed to new artificial-intelligence capabilities as an additional growth catalyst for public-safety customers. Axon: A Strong Contender in Law Enforcement Tech
• Neutral Sentiment: Technical consolidation: AXON remains in a strong broader uptrend but has recently consolidated, leaving investors watching whether momentum resumes or the rally pauses. Stock of the Day: Is the Axon Rally Over?
• Negative Sentiment: Valuation and profitability risks: Despite strong revenue growth, analysts cautioned that Axon’s high earnings multiple, elevated costs, debt and relatively modest margins reduce its near-term appeal. Memory costs and counter-drone investments could also pressure profitability if spending rises faster than sales.
• Negative Sentiment: CEO share sale: CEO Patrick Smith sold 9,930 shares worth approximately $5.45 million. The transaction occurred under a pre-arranged Rule 10b5-1 plan and represented only 0.33% of his holdings, making it a limited signal but a potential source of investor caution.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, insider Isaiah Fields sold 2,000 shares of the firm's stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $400.00, for a total value of $800,000.00. Following the completion of the sale, the insider directly owned 52,813 shares of the company's stock, valued at $21,125,200. This trade represents a 3.65% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of Axon Enterprise stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $485.00, for a total value of $753,690.00. Following the completion of the sale, the insider directly owned 34,024 shares of the company's stock, valued at approximately $16,501,640. This trade represents a 4.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 68,989 shares of company stock valued at $36,016,932 in the last quarter. Insiders own 4.20% of the company's stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source